GlaxoSmithKline Investor

GlaxoSmithKline develops and markets products in the areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.


Technology: Cell_Therapies
Industry: Cosmeceuticals
Headquarters: London, England, United Kingdom
Founded Date: 1929-01-01
Employees Number: 10001+
Funding Status: IPO
Number Of Exits: 13
Acquisitions Number: Made Acquisitions
Investors Number: 1
Total Funding: 25510000
Estimated Revenue: $10B+
Last Funding Date: 2021-03-02
Last Funding Type: Grant

Visit Website
Register and Claim Ownership